In this article, we discuss the clinical approach to patients with dropped head syndrome and identify the various neuromuscular causes of dropped head syndrome including muscle, neuromuscular junction, peripheral nerve and motor neuron etiologies. We aim to increase awareness of recognition the entity of dropped head syndrome and factors that may predict response to immunomodulating therapy in dropped head syndrome.
Introduction
The dropped head syndrome (DHS), also known as the floppy head syndrome, was first described as in 1986. 1 It was initially recognized in 12 patients with neuromuscular (NM) disorders. This syndrome is defined by weakness of neck extensor muscles against gravity with or without weakness of neck flexor muscles. It can be an isolated clinic entity presenting with difficulty raising the head or it can be part of the generalized muscular disease manifestation. In the first report, definite diagnosis was established in 9 patients; myasthenia gravis in 4; motor neuron disease in 3; polymyositis (PM), sclerodermatomyositis (SDM), and facioscapulohumeral dystrophy (FSHD) in 1. 1 Then in 1992, Suarez and Kelly described a non-inflammatory myopathy affecting predominantly neck extensors in four patients, aged 63 to 81 years and they named the DHS as a new clinical disorder, characterized by severe weakness of neck extensors with milder weakness of shoulder girdle and proximal arm muscles.
DHS is relatively rare condition that may occur as a result of several neurological, neuromuscular, muscular, and other causes. Neurological causes includes amyotrophic lateral sclerosis (ALS), 2,3 , Parkinson disease 4 , multiple system atrophy, 4, 5 cervical dystonia, 6 postpolio syndrome, 7 cervical myelopathy, [8] [9] [10] chronic inflammatory polyneuropathy (CIDP), 11 neuromuscular causes include myasthenia gravis (MG), [12] [13] [14] Lambert-Eaton myasthenia syndrome (LEMS), 15 muscular causes includes primary inflammatory such as polymyositis, 16 scleromyositis, 17, 18 isolated inflammatory axial myopathy, 19 primary non-inflammatory such as nemaline myopathy, mitochondrial myopathy, [20] [21] [22] congenital myopathy, 23 FSHD, 24 and isolated neck extensor myopathy (INEM). 19 General approach: clinical manifestation and evaluation DHS occurs as a result of weakness of posterior neck muscles. It usually disappears with supine position. The common chief complaints are "chin on the chest" and "difficulty maintaining a forward gaze". It may contribute to dysphagia and has cosmetic and social implications. 1, 12, 19, 25 Semispinalis cervicis and semispinalis capitis are primarily responsible for neck extension. DHS is thought to be directly related to weakness or laxity of the semispinalis cervicis muscles. 1, 25 During the evaluation of dropped head, providers first should rule out structural diseases of the cervical spine. To differentiate NM causes from non-NM causes is very important. In NM causes, a significant weakness of neck extensors is usually observed. In non-NM causes, imbalance of neck muscle tone leads to dystonic anterocollis. It is paramount important to identify potential treatable causes. 1, 2, 12, 19, 25 A deliberate and detailed history taking is a key factor for an accurate diagnosis and important clues can be gathered from the history. Firstly, a provider should identify pattern of involvement and characteristics of weakness. These questions should be asked if a patient has isolated neck extensor weakness or diffuse weakness; if a patient has fatigable weakness or diurnal variation; if there is any cranial and/or bulbar muscle involvement; if there is any respiratory muscle weakness; and if there are any associated symptoms such as autonomic symptoms. Detailed family and developmental history should be taken as well as history of onabotulinumtoxin A injections. 1, 2, 16, 19, 25, 26 After detailed history, cautious and complete physical examination should be performed to collect more clues for an accurate diagnosis. In the physical exam, upper and/or lower motor signs, muscle wasting/atrophy (as in motor neuron disease) , skin findings (as in dermatomyositis), ocular and bulbar weakness (as in MG), facial weakness (as in FSHD), highly selec-tive weakness pattern (as in IBM), and pelvic girdle weakness (as in most generalized myopathies) should be assesses carefully. 1, 2, 25, 27 Following physical examination, a provider should decide if further imaging tests are warranted. X-rays can be ordered to rule out kyphosis, fractures, and arthritis. Magnetic resonance imaging (MRI) is superior to Computed tomography (CT) to imagine soft tissue includes tendons, ligaments, fascia, fibrous tissues, fat, synovial membranes, muscles, and nerves. 28, 29 Contrast enhancement is sensitive to detect inflammation. MRI imaging demonstrates fatty infiltration, edema, and/or atrophy of the neck musculature. 28 Radiological imaging particularly MRI is useful for determining biopsy sites in selective cases. 28, 29 Electrodiagnostic (EDx) studies provide valuable information in the diagnosis. 30, 31 The needle study should include cervical and thoracic paraspinal, sternocleidomastoid muscle, and trapezius muscles. Facial and tongue muscles should be tested if any weakness is detected. Electromyographer should be careful not to overestimate paraspinal muscles finding during the needle testing since normal paraspinal motor unit action potentials have smaller amplitudes and a shorter duration, but the recruitment is normal as opposed to reduced or early recruitment. [30] [31] [32] Muscle biopsy can be considered in selected cases. Most of the biopsies are taken from shoulder girdle muscles including deltoid and trapezius muscles. 30, 33 Biopsy from cervical paraspinal muscles are more valuable, but more challenging because small and larger muscles are intermingled and it is difficult to know exactly which muscles should be biopsied. 30, 32 Muscle biopsy may provide valuable information particularly in diagnosis of inflammatory muscle diseases such as size variability with fibrosis ( Figure 1 ) and inflammation with some necrotic fibers ( Figure 2 ). Ultrasound guided biopsy may be helpful, but not is not widely used.
DHS in amyotrophic lateral sclerosis
Dropped head is a rare manifestation of ALS occurring around 1-3% of patients. 34 Dropped head is usually an early feature of ALS but it is usually not the presenting symptom. Neck flexor muscles weakness is usually worse than neck extensor muscles in ALS patients. DHS in ALS patients has been reported in few case reports. 2,3,34 A single-hospital-based retrospective study 34 from Japan including 105 sporadic ALS patients showed the incidence rate of DHS was 2.9% (3/105). The ages were 56, 63, and 53 years. The initial symptoms of the patients were bulbar palsy in two patients and weakness of the upper limb in one patient. 34 The onset to DHS was 14, 4 and 26 months after the onset of illness. Patients with prominent legs weakness did not develop DHS in their study. 34 Another retrospective study, 3 including 683 patients with ALS from India showed 9 of the patients (1.3%) had severe weakness of neck extensor muscles observed as an early feature, or developing during the later stages of the disease. The mean of affected patients was 53.3 (±10.3) (range 33 to 65). Six of them developed head drop as an early feature (mean interval from onset of illness was 11.6 months) and three has late onset (between three and eight years after onset). 3 In their series, none of patients developed respiratory difficulties but all had swallowing difficulties and social embracement. 3 The pathogenesis of DHS in ALS may be preferential involvement of paraspinal anterior horn cells. Electromyography (EMG) test shows denervation with no myopathic features. Muscle biopsy is usually consistent with neurogenic atrophy. 2, 12 DHS may cause neck pain and discomfort in ALS patients. DHS can cause severe impairments in activities of daily living (ADL) such as eating, dressing so ALS patients with DHS are more dependent in ADL. 12, 34 We advise ALS patients with DHS to wear a neck collar, which improve their posture, swallowing, and neck pain. 
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DHS in neuromuscular junction disorders Myasthenia gravis
Drooped head is a well-recognized feature of MG even in the absence of ocular or bulbar signs. It can be associated with or contribute to respiratory muscle weakness. Dropped head can be the presenting sign of only sign of MG. One retrospective study, 35 including 146 patients with generalized MG showed 15 patients (10%) of the patients developed head drop. Of these 15 patients, acetylcholine receptor binding antibodies (AchR Ab) were positive in 14, and anti-MuSK antibodies positive in 1. 35 Dropped head symptoms in MG patients with positive AchR Ab improved with treatments, but the patient with positive anti-MuSK Ab was refractory to multi treatments including prednisone, plasmapheresis, and mycophenolate mofetil. Shortcoming of the study was no imaging, EMG or muscle biopsies findings were reported. 35 Another case series study reported 13 MG cases with dropped head. Of those patients, 8 were positive with AchR Ab; 3 were positive with MuSK Ab; and 2 were sero negative. Eight of the patients had cervical imaging and one showed atrophic muscle changes. Two of them underwent thymectomy. Six patients had full remission, and seven has significant improvement with therapy. The outcome is usually good with effective control of myasthenic symptoms. Paraspinal muscles biopsies were not performed in the study.
Treatment-refractory MG cases should be reassessed for possible concomitant axial myopathy. First case was reported by Rodolico in 2014. 36 The patient presented with ocular, bulbar, and shoulder girdle weakness preceded head drop. The initial blood work up showed normal CK, positive AchR binding antibodies. Cervical MRI showed atrophy and fatty replacement of neck extensor muscle. EMG test showed sporadic fibrillation and myopathic motor unit action potentials (MUAPs) limited to paraspinal muscles. Deltoid muscle biopsy showed scattered centralized nuclei. The case was refractory to pyridostigmine and/or prednisone. 36 Eight more cases with MG and concomitant axial myopathy have been reported since then. Seven with positive AchR Ab and positive MuSK Ab. All patients' EMG showed myopathic MUAPs in paraspinal muscles. Three had biopsies showing fiber atrophy, endomysial inflammation with fibrosis. Five were refractory to multi-therapy including thymectomy, pyridostigmine, prednisone, intravenous immunoglobulins (IVIG), plasmapheresis, and mycophenolate mofetil. Only one had full remission and two showed some improvements.
The pathological relationship between MG and axial myopathy is unclear. Most of the reported cases are in their late 70s or early 80s. Mechanical stretch injury, loss of tissue elasticity with aging, chronic use of steroids/immunosuppressive agents may contribute myopathy process. [36] [37] [38] EMG test can be helpful for differential diagnosis but should be performed by experienced electromyographer to avoid under or overestimate. Cervical MRI imaging is useful to detect atrophy of cervical paraspinal and surroundings muscles. [36] [37] [38] In our opinion, cervical paraspinal muscle biopsy and cervical imaging are not required as a part of the initial work up in myasthenia patients with head drop since it will not change treatment approaches. Cervical paraspinal muscle biopsy and cervical imaging should be considered in treatment-refractory cases.
Lambert-Eaton myasthenic syndrome
LEMS is an autoimmune disease affecting neuromuscular junction due to antibodies production against voltage gated calcium channels (VGCC). DHS is very rare clinical presentation of LEMS. LEMS syndrome presenting with DHS has been reported twice. The first case was associated with antibodies against P/Q VGCC and his symptoms and electrophysiological abnormalities improved with oral prednisone following plasmapheresis. 15 The second case was associated with autoantibodies against N-type VGCC. 39 The patient presented with symmetric paresis (3/5) of the head extensors with pronounced muscle atrophy. She had more pronounced weakness in the evening. She had partial but sudden restoration of weakness with intravenous edrophonium. The initial blood test was negative for myasthenia gravis antibodies. She was initially admitted for sero-negative MG and treated with pyridostigmine and methyl-prednisolone. She was discharged home in an improved state. She was readmitted after 4 weeks with worsening of neck weakness and a progressive general muscle weakness as well as dysarthria and dysphagia. 39 The further work up showed positive N-type VGCC and was treated with unmodified medication with continuous and significant improvement. The serum titer of N-type VCGG specific antibodies dropped to normal that correlated with clinical improvements. 39 
DHS in peripheral neuropathy
Chronic inflammatory demyelinating polyneuropathy
DHS is very rare presentation of CIDP. Two cases have been reported on DHS with CIDP. In the first case report, a 19-year-old female with history of Guillain-Barre syndrome with fair recovery developed marked weakness of the neck extensors that she was unable to light her head. The detailed worked-up including EDx testing, cerebral spinal fluid (CSF) analyses were consistent with CIDP. She was treated with plasmapheresis, prednisone, and azathioprine but she did not have any remarkable improvement in neck extensors and shoulder girdle muscles. She had to use cervical collar for neck stabilization. 11 The second report was reported in 2006, 40 a 63 year-old patient presented with slowly progressive weakness of the neck extensor muscles developing a dropped head syndrome over a 12 months period. The detailed investigation including EMG, MRI, CSF analysis were inconclusive. Within two years, she developed fasciculations, atrophic paresis of the limbs and respiratory muscle involvement with consecutive respiratory failure. The postmortem neuropathological assessment demonstrated CIDP with involvement of the autonomic ganglia and the intramural plexus. Due to the complexity of the case the clinical diagnosis of a CIDP as cause of the dropped head syndrome was able to make after the postmortem pathological examination. 40
Charcot Marie tooth disease type 4C
In another interesting report, an 11year-old boy presented with proximal muscle weakness with facial involvement as well as dropped head and severe scoliosis. The detailed work up showed sensorimotor demyelinating polyneuropathy and genetic test confirming Charcot Marie Tooth disease type 4C. 41 Therefore early-onset inherited polyneuropathies should also be included in the differential diagnosis of patients with proximal muscle wasting associated with dropped head syndrome. 41 
DHS in muscle disorders
The DHS occurs in a variety of muscular disorders including primary inflammatory such as PM, 16, 42 scleromyositis (SM), 17, 18 isolated inflammatory axial myopathy 19 , primary non-inflammatory nemaline myopathy, mitochondrial myopathy, [20] [21] [22] congenital myopathy, 23 FSHD, 24 and isolated neck extensor myopathy. 19 Wide spectrum pathological processes associated with the myopathic DHS ranging from non-inflammatory muscle necrosis to a classic inflammatory myositis.
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Polymyositis/Scleromyositis
Inflammatory myopathies can cause DHS. In one report, two patients with myopathic dropped head syndrome presented with a predominant weakness of the neck extensor muscles. One patient had a good response to steroid and a histopathological assessment revealed PM. 16 The other one did not have a good response to steroid but the weakness was stabilized after initial progression. The muscle biopsy was consistent with a necrotizing myopathy with no evidence of inflammation. 16 In another report, 42 a 69 year-old male with history of PM presents with DHS due to a relapse of DM. DHS improved by 60-70% with 2 months with methyl-prednisone (80 mg/d) that was tapered down to 4 mg within 8 months. 42 Two patients were reported with DHS associated with SM, also known as scleroderma-PM overlap syndrome. 17 One of the cases,53 year-old women, presented with DHS with mild dysphagia. 17 She had wasting of the neck extensor as well as the shoulder girdle muscles. Serum creatinine kinase, lactate dehydrogenase, aspartate and alanine aminotransferase were elevated. EMG findings showed myopathic process with early recruitment in deltoid, iliopsoas, and quadriceps muscles. A muscle biopsy of the left deltoid showed a mild and diffuse process of necrosis and regeneration associated with major perivascular inflammatory infiltrate locates in endomysial, perimysial and epimysial tissues. The autoantibody screen revealed positive antinuclear antibody (1/640),mildly positive antineutrophilic cytoplasmic antibody (1/40), positive rheumatoid factor at 128 UI/l (normal b30), and positive anti PM-Scl antibody. Cervical MRI without gadolinium was unremarkable. She was treated with prednisone 1mg/kg. The dysphagia resolved within 2 weeks and motor weakness rapidly improved. Within two months, she was able to keep her head straight. Her condition progressively improved for one year, then remained stable. 17 The other case, 18 51year-old man presented with neck pain and inability to maintain the head erect. The detailed blood, pathological investigations were consistent with scleromyositis. He was treated with prednisone on a 60 mg/d stepdown dosage with subcutaneous methotrexate at a dose of 25 mg/wk, which resulted in remarkable improvement in neck weakness and limitations within 1 month with normalized muscle enzymes. 18 Isolated neck extensor myopathy INEM was first described in four patients in 1996. 19 The author reported four cases presented with neck extensor weakness. The age ranged from 65 to 85 years old. Only one patient had mild flexion, and shoulder abduction weakness. EMG showed myopathic findings in cervicothoracic paraspinal muscles. Results of cervical paraspinal muscle biopsies demonstrated nonspecific myopathic features. The detailed neurological investigations were inconclusive. 19 Treatment trials with pyridostigmine bromide and prednisone were attempted in 3 of them with no clinical improvement. All patients had initial progression of weakness, followed by stabilization of neck weakness with no changes in follow up. 19 The responsiveness of treatment of INEM is debatable. INEM usually has a poor response to immunosuppressive therapy because it is a non-inflammatory myopathy. 19 However, recent publications have challenged this general acceptance. [43] [44] [45] Muppidi et al. 43 reviewed four patients with INEM who received one or more immunosuppressive agents and showed neck strength improved by one or greater on the Medical Research Council scale in all patients with a peak response between 3 and 6 months after treatment initiation. They recommended a trial of immunosuppressive agents to patients with INEM. 43 As a definition, INEM is a non-inflammatory myopathy but focal myositis could be missed on muscles biopsy that may explain immunosuppressive responsiveness in some INEM cases. 43, 45 Facioscapulohumeral muscular dystrophy FSHD is rare reason of DHS. It was reported that a patient with FSHD developed dropped head caused by severe wasting of neck muscles. 46 In Kazakov et al. study, 47 the review of 200 FSHD patients showed only 4 patients had slight or moderate weakness of neck extensor muscles. In the same series, some patients with severe muscle atrophy and weakness of muscles fixing the scapula demonstrated visible dropped head because of abnormal posture of the shoulder girdle. 47
Anti-glutamic acid decarboxylaseassociated inflammatory myopathy
DHS is a complex and perplexing condition that has been reported in different neurological disease. In one of the interesting report, 48 a 78-year-old woman presented with a 10-month history of difficulty in keeping her head up during sitting and standing positions. The detailed investigation ended up with a diagnosis of anti-glutamic acid decarboxylase-associated inflammatory myopathy. Her symptom improved after intravenous immunoglobulins (0.4 g/kg/day for 5 days) followed by prednisone 25 mg/day for 2 months. 48
Adult-onset nemaline myopathy
Another cause of dropped head is adultonset nemaline myopathy. 49 In one case, 49 reported in 1999, a 59-year-old Greek painter complained of progressive pain and weakness in neck extensors, proximal legs, and shoulders for 1 year. Cramps, twitching, and atrophy were detected in the affected muscles. EMG showed myopathic abnormalities in proximal muscles with normal nerve conduction studies (NCS). Muscle biopsy demonstrated prominent muscle fiber atrophy and centrally located nuclei and electromicroscopy revealed that the atrophic fibers contained large arrays of osmiophilic oval structures, composed of Zband material. 49 In the same report, the authors reviewed previously published 11 well-documented cases of adult-onset nemaline myopathy and they showed that neck weakness was mentioned in seven cases, and four of them had severe extensor weakness. 49 After that report, several cases of nemaline myopathy related DHS are reported. 21, 22, 50, 51 
Amyloidosis
In another report, a 77-year-old man with history of lymphoma and neck radiation presented with neck extensor weakness. 52 Needle EMG showed myopathic changes, and biopsy of cervical paraspinal muscle demonstrated amyloid deposition in blood vessels. 52 In another similar case, the further investigation revealed DHS with proximal myopathy caused by AL amyloidosis. 53 Thus amyloidosis should consider in the differential diagnosis of DHS.
Mitochondrial myopathy
Mitochondrial myopathy should be part of the differential diagnosis of DHS, particularly when more common causes are excluded. DHS was the presenting manifestation of mitochondrial myopathy in two cases. 54 Detailed neurological work-up were performed to rule out common causes. The work up revealed elevated serum lactate and mitochondrial proliferation in muscle biopsy. 54 In another report, DHS was reported as result of possible multi-organ mitochondriopathy, manifesting as Parkinsonism, tetraspasticity, dilative car-diomyopathy, short stature, osteoporosis, and myopathy. In this case, neurological examination showed prominent neck extensor weakness, weakness of the shoulder gridle, cogwheel rigidity, and tetraspacticity. The further tests showed elevated serum lactate, myogenic findings in needle EMG, and myogenic abnormalities with weak staining of cytochrome oxidase in muscle biopsy. No improvement of the clinical symptoms with anti-Parkinson medications. Based on those findings, mitochondriopathy with multi-organ involvement was suspected. 55 Other myopathies DHS can be caused by several different types of primary or secondary myopathies. It is difficult to summarize all those reports in this article. In this section, we only provide the name of myopathies and its related references. It is paramount important to recognize the causes of secondary myopathies that may be a treatable cause of DHS. Other reasons of secondary myopathies include Cushing syndrome, 56 carnitine deficiency, 57-59 hypothyroidism, 60-62 hypokalemia, [63] [64] [65] hyperparathyroidism, [66] [67] [68] and post-radiation neck extensor myopathy. [69] [70] [71] [72] Conclusions DHS is relatively rare condition that may occur as a result of several neurological, neuromuscular, muscular, and other causes. It is important to differentiate NM and non-NM causes to offer best treatment options to patients. Detailed history taking, physical examinations are key to make an accurate diagnosis. EDx studies, MRI imaging, and paraspinal muscle biopsy can provide valuable information in selected cases. We aim to increase awareness of recognition the entity of dropped head syndrome and factors that may predict response to immunomodulating therapy in dropped head syndrome.
